Last reviewed · How we verify
NCT05645133
QPlus Pediatric Reference Interval
trial testing Diagnostic Test in Pediatric ALL in 93 participants. Terminated before completion.
1 June 2023
Quick facts
| Lead sponsor | HemoSonics LLC |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 93 |
| Start date | 27 February 2023 |
| Primary completion | 1 June 2023 |
| Estimated completion | 10 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Diagnostic Test
Conditions studied
- Pediatric ALL — all drugs for Pediatric ALL →
- Healthy — all drugs for Healthy →
Sponsor
HemoSonics LLC — full company profile →
Who can join
Under 17, any sex, with Pediatric ALL or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05645133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diagnostic Test
Trials testing the same drug.
- NCT06394050 — Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Trea · not yet recruiting
- NCT06320886 — Role of Ultrasonography in Acute Abdomen in Adults in Correlation to Computed Tomography Scan · unknown
- NCT05663671 — Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD · unknown
- NCT05752708 — Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery · recruiting
- NCT05383456 — The Visceral Adiposity Measurement and Observation Study · completed
Other recruiting trials for Pediatric ALL
Currently open trials in the same condition.
- NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
- NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
- NCT06325280 — Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease · recruiting
- NCT06274788 — Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome · recruiting
- NCT06096272 — Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy · NA · recruiting
Other HemoSonics LLC trials
Trials by the same sponsor.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06255496 — QStat Cartridge in Obstetric Patients · completed
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT06025708 — Quantra QStat Sample Type Comparison · completed
- NCT05875987 — Evaluation of the Quantra QStat System in Obstetric Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05645133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HemoSonics LLC
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05645133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing